TIS 0.00% 0.0¢ tissue therapies limited

defer us trials until cashflow, page-29

  1. 2,243 Posts.
    lightbulb Created with Sketch. 109
    pp -- you have NEVER expressed an opinion...come on tell me what are your thoughts and reasoned arguments about the position then? do you think it is a good idea to keep spending inordinate amounts on R & D? Do you want to see a $10-15 million CR at 15-18c? What are your reasons for this point of view? I mean for god's sake, I am all for exchanges of views but bloody hell, time and again, myself and 1 or 2 other posters who have thought deeply about the issues put them out on a public forum for debate and the best you can come up with is "ring management"????
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.